Serious Warnings Omitted From Ad Promoting Opioid Dependence Treatment
While claims about the benefits of Vivitrol were clearly presented in the ad, serious risks, such as vulnerability to opioid overdose, were not communicated.
Opioids
Prevalence of Prescription Opioid Analgesic Use Among US Adults
Overall, 6.5 percent of adults aged 20 years and older reported using a prescription opioid analgesic in the previous 30 days during 2013 to 2016.
Addressing Dual Public Health Epidemics: Suicide and Opioid Addiction
Traditionally, suicide and overdose prevention in opioid use disorder involve stratifying risk based on certain demographic and clinical factors.
The Shifting Racial Demographics of Synthetic Opioid-Related Overdose Deaths
A recent study published by the Centers for Disease Control and Prevention analyzed how rates of overdose deaths changed between 2015 and 2017 in people aged 18 years and older.
Mind-Body Therapy May Be Effective for Opioid-Treated Pain
Mind-body therapies were linked with small declines in opioid dose, a promising finding in light of concerns surrounding the scale of opioid prescriptions in the United States.
Daily Cannabis Use Tied to Lower Illicit Opioid Use for Chronic Pain
Individuals with chronic pain who use daily cannabis have lower odds of using illicit opioids.
Advance Practice Providers Still Encounter Barriers to Prescribing Buprenorphine
Researchers sought to describe the practice patterns of NPs and PAs, understand the barriers these providers face in providing buprenorphine treatment, and compare them with their physician counterparts and across varying levels of practice autonomy.
Depressive Symptoms Linked to Opioid Misuse Risk in Adults With PTSD
Overall, of 333 adult patients, 15.9% of patients reported opioid misuse, 17.1% were positive for PTSD, and 52.6% were positive for depression.
FDA Rejects NDA for Investigational High Dose Naloxone Product
The FDA has issued a Complete Response Letter (CRL) to Adamis Pharmaceuticals regarding the New Drug Application (NDA) for Zimhi, an investigational high-dose naloxone injection product, for the treatment of opioid overdose.
Prescription Opioid Misuse Among Adolescents in the United States
Prescription opioid use among teens and young adults is higher than expected, with most obtaining the drugs from friends and family.
Next post in General Pain
